← Browse by Condition
Medical Condition
carcinoma non small cell lung
Total Trials
9
Recruiting Now
9
Trial Phases
Phase 1, Phase 2, Phase 3, Phase 2
ClinicalMetric tracks all active clinical trials for carcinoma non small cell lung sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — carcinoma non small cell lung Clinical Trials
How many clinical trials are currently recruiting for carcinoma non small cell lung?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for carcinoma non small cell lung, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for carcinoma non small cell lung?
carcinoma non small cell lung research spans Phase 1 (4 trials), Phase 2 (4 trials), Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a carcinoma non small cell lung clinical trial?
Eligibility criteria for carcinoma non small cell lung trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 4
Phase 2 4
Phase 3 2
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06694454 Phase 1, Phase 2
Recruiting
Enrollment
60 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT05487391 Phase 3
Recruiting
Enrollment
632 pts
Location
China
Sponsor
Qilu Pharmaceutical Co., Ltd.
NCT06855771 Phase 2
Recruiting
Enrollment
130 pts
Location
United States, Austr...
Sponsor
Bristol-Myers Squibb
NCT07227298 Phase 1, Phase 2
Recruiting
Enrollment
162 pts
Location
United States, China...
Sponsor
Pfizer
NCT06687941 Phase 1
Recruiting
Enrollment
70 pts
Location
South Korea
Sponsor
Aptamer Sciences, Inc.
NCT06431633 Phase 3
Recruiting
Enrollment
129 pts
Location
Spain
Sponsor
Fundación GECP
NCT06667076 Phase 2
Recruiting
Enrollment
480 pts
Location
United States, Belgi...
Sponsor
Janssen Research & Development...
NCT04165798
Recruiting
Enrollment
1,065 pts
Location
United States, Hunga...
Sponsor
Merck Sharp & Dohme LLC
NCT07046923 Phase 1
Recruiting
Enrollment
240 pts
Location
United States, China...
Sponsor
Eli Lilly and Company
Related Conditions
non small cell lung carcinoma (2) non small cell lung cancer (2) non small cell lung cancer nsclc (1) advanced metastatic non small cell lung cancer (1) neoplasms (1) carcinoma hepatocellular (1) liver neoplasms (1) lung diseases (1) resectable lung non small cell carcinoma (1) small cell lung carcinoma (1) endometrial neoplasms (1) neoplasm metastasis (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology